ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

NCT06922539 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: Fenretinide
DRUG: Fenretinide

Sponsor

SciTech Development, Inc.